Trending...
- AEVIGRA (AEIA) Analysis Reveals $350 Billion Counterfeit Market Driving Luxury Sector Toward Blockchain Authentication
- Best Companies Group Launches Free Best Places to Work in Georgia Program
- YuanziCoin Unveils Revolutionary Shariah-Compliant Blockchain Architecture for 1.8 Billion Muslims Worldwide
PHILADELPHIA, Sept. 15, 2025 /PRNewswire/ -- Berger Montague, a national securities litigation law firm, advises shareholders of Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) about an investigation into Hims & Hers' Board of Directors for potential breaches of fiduciary duties to the Company and its shareholders in connection with Novo Nordisk A/S's termination of its partnership with Hims & Hers.
Shareholders of HIMS & HERS may learn more about this investigation by contacting Berger Montague: Radha Raghavan at [email protected] or (332) 271-8908, or Andrew Abramowitz at [email protected] or (215) 875-3015 or by CLICKING HERE.
More on The PennZone
Berger Montague's investigation is focused on whether Hims & Hers' Board of Directors breached its fiduciary duties in the manner in which it oversaw the Company's partnership with Novo Nordisk, including in connection with Novo Nordisk's announcement in June 2025 that it was terminating its partnership with Hims & Hers on the basis that the Company had engaged in deceptive marketing practices with respect to unapproved compounded versions of semaglutide.
Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco, Chicago, Malvern, PA, and Toronto has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
More on The PennZone
Contacts:
Radha Raghavan, Associate
Berger Montague
(332) 271-8908
[email protected]
Andrew Abramowitz, Senior Counsel
Berger Montague
(215) 875-3015
[email protected]
SOURCE Berger Montague
Shareholders of HIMS & HERS may learn more about this investigation by contacting Berger Montague: Radha Raghavan at [email protected] or (332) 271-8908, or Andrew Abramowitz at [email protected] or (215) 875-3015 or by CLICKING HERE.
More on The PennZone
- InventHelp Inventor Develops Means to Generate Power from Pipelines (ACC-446)
- DecisionPoint Technologies Accelerates Growth with Acquisition of Acuity Technologies
- CCHR: Involuntary Commitment Is Eugenics Repackaged as "Mental Health Care"
- Q2 2025 Industry Impact Report Underscores Semiconductor Expansion, Talent Development and Sustainability Milestones
- 84 Ethiopian Churches Change Signboards to Shincheonji Church of Jesus
Berger Montague's investigation is focused on whether Hims & Hers' Board of Directors breached its fiduciary duties in the manner in which it oversaw the Company's partnership with Novo Nordisk, including in connection with Novo Nordisk's announcement in June 2025 that it was terminating its partnership with Hims & Hers on the basis that the Company had engaged in deceptive marketing practices with respect to unapproved compounded versions of semaglutide.
Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco, Chicago, Malvern, PA, and Toronto has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
More on The PennZone
- BTXSGG Outlines Four-Pillar Framework to Enhance Digital Asset Security and Compliance
- STRETCH ZONE CELEBRATES GRAND OPENING IN CONSHOHOCKEN, PA
- NJTRX Positions for Next-Generation Asset Trading with U.S. Regulatory Framework
- Poncho Tha Popstar: The West's Next King
- Physician-Turned-Patient Launches Advocacy Campaign to Spotlight Disability Insurance Barriers
Contacts:
Radha Raghavan, Associate
Berger Montague
(332) 271-8908
[email protected]
Andrew Abramowitz, Senior Counsel
Berger Montague
(215) 875-3015
[email protected]
SOURCE Berger Montague
Filed Under: Business
0 Comments
Latest on The PennZone
- Arc Intermedia Brings Humanity Back to Digital Marketing
- Counseling Center of New Smyrna Beach Expands Affordable Mental Health Services for Volusia County
- Athena Forge (ATFG) Introduces Advanced Token for Technology-Driven Financial Ecosystem
- Albuquerque's Z-CoiL Footwear Brings All-American Family Business Story to Shark Tank Season Premiere
- NoviSign Sponsoring VARTECH 2025 - the B2B IT channel's #1 event
- Unicorp and BH Group Select Chasing Creative—Palm Coast Agency—to Lead Growth Marketing for The Ritz-Carlton Residences, Hammock Dunes
- Breaking: 50+ runners from 20+ states relay custom 9/11 flag 485 miles from Shanksville through DC to Ground Zero for memorial remembrance run
- SecureMaine 2025 is this October 8th in Portland, Maine
- John Thomas calls for unity and prayer after tragic loss
- Where the Miami Dolphins Stand After Week 1
- Which NFL Teams Can Rebound from Week 1? OddsTrader Breaks Down the Biggest Questions
- Apellix Deploys Breakthrough Spray-Painting Drones into Live Service Limited Beta Program Open for Advanced Contractors
- DivX Unveils New Educational Blog Series to Simplify MKV to MP4 Video Conversion
- 123Invent Inventor Develops Blood Collection Tube with a Modified Lid (LBT-7903)
- Best Companies Group Launches Great Employers to Work for in North Carolina Program
- CCHR: For Prevention, Families Deserve Truth From NIH Study on Psychiatric Drugs
- Sheets.Market Brings Professional Financial Model Templates to Entrepreneurs and Startups
- Webinar Announcement: Investing in the European Defense Sector—How the New Era of Uncertainty Is Redefining Investment Strategies
- AEVIGRA (AEIA) Analysis Reveals $350 Billion Counterfeit Market Driving Luxury Sector Toward Blockchain Authentication
- Her Magic Mushroom Memoir Launches as a Binge-Worthy Novel-to-Podcast Experience